What do PAs need to know about prescription drug monitoring programs?

被引：1

作者：

Mospan, Geoffrey A. ^{[1
]}

Lucas, Austin ^{[2
]}

机构：

[1] Wingate Univ, Sch Pharm, Pharm Pharm Law & Internal Med, Wingate, NC 28174 USA

[2] Wingate Univ, Sch Pharm, Wingate, NC USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2017年 / 30卷 / 07期

关键词：

prescription drug monitoring programs; opioid epidemic; opioids; controlled substances; abuse; misuse; UNITED-STATES; IMPACT;

D O I：

10.1097/01.JAA.0000520545.53946.82

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

As controlled-substance abuse continues to increase in the United States, clinicians find themselves on the front lines of this epidemic. State-operated prescription drug monitoring programs are a valuable resource that prescribers can use to see patients' controlled substance history. Despite some limitations, these programs have been shown to be an effective method in reducing overdose deaths and the supply of controlled substances in the community.

引用

页码：11 / 12

页数：2

共 50 条

[11] What Do Nurses Need to Know About the Quality Enterprise? [J].

Farquhar, Marybeth ;

Kurtzman, Ellen T. ;

Thomas, Kimberly Arrington .

JOURNAL OF CONTINUING EDUCATION IN NURSING, 2010, 41 (06) :246-256

[12] ABC's of Controlled Medications: What Patients Need to Know about their Prescription Pain Medicine [J].

Boyd, Carol J. ;

Anderson, Kristen G. ;

Rieckmann, Traci .

JOURNAL OF ADDICTIONS NURSING, 2011, 22 (04) :168-170

[13] Must-access prescription drug monitoring programs and retail opioid sales [J].

Shakya, Shishir ;

Hodges, Collin .

CONTEMPORARY ECONOMIC POLICY, 2023, 41 (01) :146-165

[14] A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs [J].

Carnes, Neal A. ;

Wright, Eric R. ;

Norwood, Connor W. .

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2017, 13 (06) :1167-1174

[15] How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program [J].

Buchmueller, Thomas C. ;

Carey, Colleen M. ;

Meille, Giacomo .

HEALTH ECONOMICS, 2020, 29 (09) :957-974

[16] Prescription drug monitoring programs and neonatal outcomes [J].

Gihleb, Rania ;

Giuntella, Osea ;

Zhang, Ning .

REGIONAL SCIENCE AND URBAN ECONOMICS, 2020, 81

[17] State Prescription Drug Monitoring Programs and Fatal Drug Overdoses [J].

Nam, Young Hee ;

Shea, Dennis G. ;

Shi, Yunfeng ;

Moran, John R. .

AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (05) :297-U131

[18] Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs [J].

Bachhuber, Marcus A. ;

Saloner, Brendan ;

LaRochelle, Marc ;

Merlin, Jessica S. ;

Maughan, Brandon C. ;

Polsky, Dan ;

Shaparin, Naum ;

Murphy, Sean M. .

PAIN MEDICINE, 2018, 19 (10) :1952-1960

[19] Framework for Advancing Epidemiological Criminology Research on Prescription Drug Monitoring Programs [J].

Delcher, Chris ;

Goodin, Amie .

AMERICAN JOURNAL OF CRIMINAL JUSTICE, 2021, 46 (04) :665-681

[20] Prescription Drug Monitoring Programs and Opioid Overdoses Exploring Sources of Heterogeneity [J].

Castillo-Carniglia, Alvaro ;

Ponicki, William R. ;

Gaidus, Andrew ;

Gruenewald, Paul J. ;

Marshall, Brandon D. L. ;

Fink, David S. ;

Martins, Silvia S. ;

Rivera-Aguirre, Ariadne ;

Wintemute, Garen J. ;

Cerda, Magdalena .

EPIDEMIOLOGY, 2019, 30 (02) :212-220

← 1 2 3 4 5 →